Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, USA.
PLoS Med. 2010 Dec 7;7(12):e1000374. doi: 10.1371/journal.pmed.1000374.
A number of epidemiologic studies have observed an association between secondhand smoke (SHS) exposure and pediatric invasive bacterial disease (IBD) but the evidence has not been systematically reviewed. We carried out a systematic review and meta-analysis of SHS exposure and two outcomes, IBD and pharyngeal carriage of bacteria, for Neisseria meningitidis (N. meningitidis), Haemophilus influenzae type B (Hib), and Streptococcus pneumoniae (S. pneumoniae).
Two independent reviewers searched Medline, EMBASE, and selected other databases, and screened articles for inclusion and exclusion criteria. We identified 30 case-control studies on SHS and IBD, and 12 cross-sectional studies on SHS and bacterial carriage. Weighted summary odd ratios (ORs) were calculated for each outcome and for studies with specific design and quality characteristics. Tests for heterogeneity and publication bias were performed. Compared with those unexposed to SHS, summary OR for SHS exposure was 2.02 (95% confidence interval [CI] 1.52-2.69) for invasive meningococcal disease, 1.21 (95% CI 0.69-2.14) for invasive pneumococcal disease, and 1.22 (95% CI 0.93-1.62) for invasive Hib disease. For pharyngeal carriage, summary OR was 1.68 (95% CI, 1.19-2.36) for N. meningitidis, 1.66 (95% CI 1.33-2.07) for S. pneumoniae, and 0.96 (95% CI 0.48-1.95) for Hib. The association between SHS exposure and invasive meningococcal and Hib diseases was consistent regardless of outcome definitions, age groups, study designs, and publication year. The effect estimates were larger in studies among children younger than 6 years of age for all three IBDs, and in studies with the more rigorous laboratory-confirmed diagnosis for invasive meningococcal disease (summary OR 3.24; 95% CI 1.72-6.13).
When considered together with evidence from direct smoking and biological mechanisms, our systematic review and meta-analysis indicates that SHS exposure may be associated with invasive meningococcal disease. The epidemiologic evidence is currently insufficient to show an association between SHS and invasive Hib disease or pneumococcal disease. Because the burden of IBD is highest in developing countries where SHS is increasing, there is a need for high-quality studies to confirm these results, and for interventions to reduce exposure of children to SHS.
多项流行病学研究观察到二手烟(SHS)暴露与小儿侵袭性细菌性疾病(IBD)之间存在关联,但尚未对此进行系统评价。我们进行了一项系统评价和荟萃分析,评估了 SHS 暴露与三种疾病(脑膜炎奈瑟菌(N. meningitidis)、流感嗜血杆菌(Hib)和肺炎链球菌(S. pneumoniae))的两个结局(IBD 和咽部分泌物细菌携带)之间的关系。
两位独立的审查员搜索了 Medline、EMBASE 和其他选定的数据库,并对文章进行了纳入和排除标准的筛选。我们确定了 30 项关于 SHS 和 IBD 的病例对照研究,以及 12 项关于 SHS 和细菌携带的横断面研究。对于每个结局和具有特定设计和质量特征的研究,计算了加权汇总比值比(OR)。进行了异质性和发表偏倚检验。与未暴露于 SHS 的人群相比,暴露于 SHS 的人群患侵袭性脑膜炎球菌病的汇总 OR 为 2.02(95%置信区间[CI] 1.52-2.69),侵袭性肺炎球菌病为 1.21(95% CI 0.69-2.14),侵袭性 Hib 病为 1.22(95% CI 0.93-1.62)。对于咽部分泌物细菌携带,脑膜炎奈瑟菌的汇总 OR 为 1.68(95% CI,1.19-2.36),肺炎链球菌为 1.66(95% CI 1.33-2.07),Hib 为 0.96(95% CI 0.48-1.95)。SHS 暴露与侵袭性脑膜炎球菌和 Hib 疾病之间的关联不受结局定义、年龄组、研究设计和发表年份的影响。对于所有三种 IBD,6 岁以下儿童的研究以及侵袭性脑膜炎球菌病的更严格实验室确诊诊断的研究中,效应估计值更大(汇总 OR 3.24;95% CI 1.72-6.13)。
结合直接吸烟和生物学机制的证据,我们的系统评价和荟萃分析表明,SHS 暴露可能与侵袭性脑膜炎球菌病有关。目前,流行病学证据不足以表明 SHS 与侵袭性 Hib 病或肺炎球菌病之间存在关联。由于 IBD 的负担在 SHS 不断增加的发展中国家最高,因此需要进行高质量的研究来证实这些结果,并采取干预措施减少儿童接触 SHS。